CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
231 hedge funds and large institutions have $6.42B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 82 increasing their positions, 69 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $6.67B → $6.42B (-$254M)
12% less call options, than puts
Call options by funds: $149M | Put options by funds: $169M
Holders
231
Holding in Top 10
16
Calls
$149M
Puts
$169M
Top Buyers
| 1 | +$65.9M | |
| 2 | +$43.3M | |
| 3 | +$37.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$35.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$32.1M |
Top Sellers
| 1 | -$77.2M | |
| 2 | -$73.1M | |
| 3 | -$50.3M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$37.5M |
| 5 |
Man Group
London,
United Kingdom
|
-$26.2M |